Skip to main content
SpringerLink
Log in

Novel FGFR3 rearrangement t(4;22)(p16;q11.2) in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Döhner H, Stilgenbauer S, Benner A et al (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343(26):1910–1916

    Article  PubMed  Google Scholar 

  2. Chang H, Stewart AK, Qi XY et al (2005) Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma. Blood 106(1):353–355

    Article  PubMed  CAS  Google Scholar 

  3. Decker T, Schneller F, Sparwasser T et al (2000) Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood 95(3):999–1006

    PubMed  CAS  Google Scholar 

  4. Jahrsdorfer B, Mühlenhoff L, Blackwell SE et al (2005) B-cell lymphomas differ in their responsiveness to CPG oligodeoxynucleotides. Clin Cancer Res 11(4):1490–1499

    Article  PubMed  CAS  Google Scholar 

  5. Bacher U, Haferlach T, Schnittgel S, Weiss T et al (2010) Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics 200(2):170–174

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

The authors have no competing interests.

Author information

Authors and Affiliations

  1. Department Medicine, Division of Hematology/Oncology, UMass Memorial Medical Center, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA

    Jan Cerny

  2. Department of Pathology, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, MA, USA

    Hongbo Yu & Patricia M. Miron

Authors
  1. Jan Cerny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongbo Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia M. Miron
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Cerny.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cerny, J., Yu, H. & Miron, P.M. Novel FGFR3 rearrangement t(4;22)(p16;q11.2) in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma. Ann Hematol 92, 1433–1435 (2013). https://doi.org/10.1007/s00277-013-1736-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1736-y

Keywords

Search

Navigation